Last reviewed · How we verify
RX0041 4%
This drug is a small molecule that targets the serotonin receptor.
This drug is a small molecule that targets the serotonin receptor. Used for Major depressive disorder, Generalized anxiety disorder.
At a glance
| Generic name | RX0041 4% |
|---|---|
| Also known as | Topical Anesthetic |
| Sponsor | Pharmaceutical Project Solutions, Inc. |
| Drug class | SSRI |
| Target | 5-HT receptor |
| Modality | Small molecule |
| Therapeutic area | Psychiatry |
| Phase | Phase 3 |
Mechanism of action
It works by selectively binding to the serotonin receptor, which leads to a decrease in serotonin levels in the brain. This decrease in serotonin levels is associated with a reduction in anxiety symptoms.
Approved indications
- Major depressive disorder
- Generalized anxiety disorder
Common side effects
- Nausea
- Headache
- Dizziness
- Fatigue
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |